[1]
“Dipeptidyl-Peptidase IV inhibitors and glycemic control in type 2 Diabetes Mellitus”, J Coll Med Sci-Nepal, vol. 12, no. 1, pp. 28–32, Mar. 2016, doi: 10.3126/jcmsn.v12i1.14684.